Register entry
LXO IRELAND DESIGNATED ACTIVITY CO
- Registered sites
- 0
- Active NDC listings
- 0
- Live patents
- 28
- Countries
- 0
Exclusivity
Patents and exclusivities
28| Patent | Product | Covers | Expiry |
|---|---|---|---|
| 10525033 | BARHEMSYSamisulpride | product | Mar 2031 |
| 12194022 | BARHEMSYSamisulpride | use | Mar 2031 |
| 9545426 | BARHEMSYSamisulpride | use | Mar 2031 |
| 9889118 | BARHEMSYSamisulpride | use | Mar 2031 |
| 9084765 | BARHEMSYSamisulpride | use | Feb 2034 |
| 10016407 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 10149843 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 10231961 | GOPRELTOcocaine hydrochloride | product | Feb 2037 |
| 10413505 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 10420760 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 10857095 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 10894012 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 10933060 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 10973811 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 10987347 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 11040032 | GOPRELTOcocaine hydrochloride | product | Feb 2037 |
| 9867815 | GOPRELTOcocaine hydrochloride | use | Feb 2037 |
| 11357753 | BARHEMSYSamisulpride | use | Feb 2038 |
| 12005042 | BARHEMSYSamisulpride | use | Feb 2038 |
| 12329740 | BARHEMSYSamisulpride | use | Feb 2038 |
Enquiry
Common questions
- Is LXO IRELAND DESIGNATED ACTIVITY CO FDA approved?
- LXO IRELAND DESIGNATED ACTIVITY CO holds no registered establishment of its own; it appears here on its Orange Book patents.
Compiled from FDA establishment registrations, the openFDA NDC Directory, the Orange Book and the FDA drug shortage database. Not claimed by the company. Sources and methodology.